Vr Adviser, LLC Top Holdings and 13F Report (2024) About Vr Adviser, LLCInvestment ActivityVr Adviser, LLC has $1.91 billion in total holdings as of September 30, 2024.Vr Adviser, LLC owns shares of 38 different stocks, but just 16 companies or ETFs make up 80% of its holdings.Approximately 6.08% of the portfolio was purchased this quarter.About 3.91% of the portfolio was sold this quarter.This quarter, Vr Adviser, LLC has purchased 35 new stocks and bought additional shares in 5 stocks.Vr Adviser, LLC sold shares of 6 stocks and completely divested from 1 stock this quarter.Largest Holdings APOGEE THERAPEUTICS INC $498,897,676Ocular Therapeutix $111,033,419Enliven Therapeutics $102,832,494Viridian Therapeutics $88,331,630Applied Therapeutics $83,512,500 Largest New Holdings this Quarter ORUKA THERAPEUTICS INC $75,628,546 HoldingARTIVA BIOTHERAPEUTICS INC $24,867,841 HoldingINSTIL BIO INC $2,233,476 HoldingTENAX THERAPEUTICS INC $720,832 Holding Largest Purchases this Quarter ORUKA THERAPEUTICS INC 3,085,620 shares (about $75.63M)ARTIVA BIOTHERAPEUTICS INC 1,609,569 shares (about $24.87M)CASI Pharmaceuticals 875,573 shares (about $5.39M)ENGENE HOLDINGS INC 739,858 shares (about $4.88M)Applied Therapeutics 282,129 shares (about $2.40M) Largest Sales this Quarter Edgewise Therapeutics 818,182 shares (about $21.84M)Merus 355,251 shares (about $17.75M)Zura Bio 4,000,000 shares (about $16.24M)DIANTHUS THERAPEUTICS INC 350,000 shares (about $9.58M)Arvinas 173,338 shares (about $4.27M) Sector Allocation Over TimeMap of 500 Largest Holdings ofVr Adviser, LLC Selling Neutral Buying Latest 13F Holdings and Changes Since Previous Quarterly FilingIssuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSectorAPOGEE THERAPEUTICS INC$498,897,6760.0%8,493,32126.1%COMOCULOcular Therapeutix$111,033,4190.0%12,762,4625.8%MedicalELVNEnliven Therapeutics$102,832,4940.0%4,026,3315.4%MedicalVRDNViridian Therapeutics$88,331,630$865 ▲0.0%3,882,7094.6%MedicalAPLTApplied Therapeutics$83,512,500$2,398,097 ▲3.0%9,825,0004.4%MedicalSPYRE THERAPEUTICS INC$78,979,0260.0%2,685,4484.1%COM NEWDYNE THERAPEUTICS INC$78,086,9550.0%2,173,9134.1%COMORUKA THERAPEUTICS INC$75,628,546$75,628,546 ▲New Holding3,085,6204.0%COMKALVKalVista Pharmaceuticals$72,371,8850.0%6,249,7313.8%MedicalPHVSPharvaris$62,886,6230.0%3,395,6063.3%MedicalCOGTCogent Biosciences$61,389,0040.0%5,684,1673.2%MedicalDIANTHUS THERAPEUTICS INC$47,760,933$9,583,000 ▼-16.7%1,744,3732.5%COMFDMT4D Molecular Therapeutics$47,564,0000.0%4,400,0002.5%MedicalMRUSMerus$45,361,831$17,748,340 ▼-28.1%907,9632.4%MedicalORICORIC Pharmaceuticals$45,043,9020.0%4,394,5272.4%MedicalERASErasca$44,270,2700.0%16,216,2162.3%MedicalPRAXIS PRECISION MEDICINES I$40,630,7780.0%706,1312.1%COM NEWATXSAstria Therapeutics$38,079,681$1,651,500 ▼-4.2%3,458,6452.0%MedicalTERNTerns Pharmaceuticals$28,439,8840.0%3,410,0581.5%MedicalAQSTAquestive Therapeutics$27,666,6640.0%5,555,5551.4%MedicalEWTXEdgewise Therapeutics$26,690,000$21,837,278 ▼-45.0%1,000,0001.4%MedicalARTIVA BIOTHERAPEUTICS INC$24,867,841$24,867,841 ▲New Holding1,609,5691.3%COMENGENE HOLDINGS INC$23,534,551$4,883,063 ▲26.2%3,565,8411.2%COMCGEMCullinan Therapeutics$23,100,6140.0%1,379,9651.2%MedicalMRSNMersana Therapeutics$21,409,9200.0%11,328,0001.1%MedicalTSHATaysha Gene Therapies$18,090,0000.0%9,000,0000.9%MedicalABIVAX SA$15,503,3860.0%1,345,7800.8%SPONSORED ADSTRVITrevi Therapeutics$11,431,671$63 ▲0.0%3,422,6560.6%MedicalARVNArvinas$11,193,104$4,269,315 ▼-27.6%454,4500.6%MedicalADVERUM BIOTECHNOLOGIES INC$10,298,6770.0%1,467,0480.5%COM NEWIPSCCentury Therapeutics$9,215,6330.0%5,389,2590.5%MedicalZURAZura Bio$8,214,054$16,240,000 ▼-66.4%2,023,1660.4%MedicalPERCEPTIVE CAP SOLUTIONS COR$7,515,0000.0%750,0000.4%CL A ORD SHSCABACabaletta Bio$7,381,8530.0%1,563,9520.4%MedicalCASICASI Pharmaceuticals$6,081,515$5,393,529 ▲784.0%987,2590.3%MedicalTNYATenaya Therapeutics$3,002,2230.0%1,555,5560.2%MedicalINSTIL BIO INC$2,233,476$2,233,476 ▲New Holding33,1770.1%COM NEWTENAX THERAPEUTICS INC$720,832$720,832 ▲New Holding208,3330.0%COM NEWABIOARCA biopharma$0$3,318,216 ▼-100.0%00.0%MedicalShowing largest 100 holdings. View all holdings. More Institutional Buying and Selling Information SEC Filings and Trading Data SEC Filings 13F Filings Top 13F Buys Top 13F Sells Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
